Effects of a Specific Substance in Smokers
Part of paid clinical trials in Portland, Oregon.
- Sponsor
- Oregon Health and Science University
- Study ID
- NCT04281979
- Status
- Recruiting
Conditions
- Smoking
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - 40 Years
- Healthy Volunteers
- Accepted
Interventions
- Study Agent — DRUGThe study agent will be administered via beverages and/or a capsule. The substances used in the study are legal, non-prescription, and are proven safe for human consumption at the doses used. The study agent may be a depressant (such as alcohol), a stimulant (such as caffeine), or an analgesic (such as aspirin).
- Placebo — DRUGIn the placebo conditions participants will consume beverages and capsules that contain no or very small quantities of the study agent.
Study Details
Although rates of cigarette use are declining, the proportion of nondaily smokers is rising, particularly among young adults. Among young adults, nondaily smoking is associated with negative health consequences and, for some, may lead to the establishment of life-long smoking patterns. The goal of this project is to understand the behavioral, psychological and neurobiological factors that contribute to cigarette use in nondaily smokers to aid the development of tailored evidence-based interventions.
Key Dates
- Start date
- Feb 25, 2020
- Status verified
- Jul 2025
- Primary completion
- Dec 31, 2025
- Completion
- Dec 31, 2025
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Study Agent
- Placebo Comparator: Placebo
Primary Outcome Measure
Impulsivity [ Time Frame: Immediately after beverage/capsule consumption ]
Central Contacts
- Angelica M Morales, PhD503-494-4221
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Oregon Health and Science University | Portland | Oregon | 97239 |
Find similar trials in Portland, OR
By research site
Related Studies
- Impact of Daridorexant on Sleep, Daytime Alertness, and SmokingPHASE4 · Not Yet Recruiting · Legacy Health System · Portland, Oregon
- Collection of Airway, Blood and/or Urine Specimens From Subjects for Research StudiesRecruiting · Weill Medical College of Cornell University · New York, New York
- Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible SmokersRecruiting · University of California, San Francisco · San Francisco, California
- Integrating Financial Coaching and Smoking Cessation CoachingPHASE3 · Recruiting · NYU Langone Health · New York, New York